Goldman Sachs Group Inc Milestone Pharmaceuticals Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 119,449 shares of MIST stock, worth $241,286. This represents 0.0% of its overall portfolio holdings.
Number of Shares
119,449Holding current value
$241,286% of portfolio
0.0%Shares
15 transactions
Others Institutions Holding MIST
# of Institutions
53Shares Held
18.6MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$10 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY2.83MShares$5.72 Million0.32% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$5.06 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.62 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.83 Million1.22% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $60.6M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...